Whole-brain radiotherapy in primary CNS lymphoma

The Lancet Oncology

Volumn 12, Issue 2, 2011, Pages 118-119

  Ferreri, Andrés JM ^a   DeAngelis, Lisa ^b   Illerhaus, Gerald ^c   O'Neill, Brian P ^d   Reni, Michele ^a   Soussain, Carole ^e   Yahalom, Joachim ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

^d MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^e INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; LETTER; NEUROTOXICITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT RESPONSE; WHOLE BRAIN RADIOTHERAPY;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CRANIAL IRRADIATION; HUMANS; LYMPHOMA;

EID: 79251471440     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70018-3     Document Type: Letter

References (5)

1. Thiel E, Korfel A, Martus P, et al. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 2010, 11:1036-1047.
2. Cabanillas F How important is whole brain radiotherapy for treatment of primary CNS lymphoma?. Lancet Oncol 2010, 11:1011-1012.
3. Korfel A, Martus P, Nowrousian MR, et al. Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma. Br J Haematol 2005, 128:177-183.
4. Nguyen PL, Chakravarti A, Finkelstein DM, et al. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol 2005, 23:1507-1513.
5. Fliessbach K, Helmstaedter C, Urbach H, et al. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology 2005, 64:1184-1188.